Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.7.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Jun. 30, 2017
Dec. 31, 2016
Current Assets:    
Cash and Cash Equivalents $ 11,763,137 $ 3,635,224
Grant Fees Receivable 146,078 37,349
Prepaid Expenses and Other Current Assets 519,559 464,981
Current Portion of Refundable Tax Credit Receivable 17,708 16,484
Total Current Assets 12,446,482 4,154,038
Property and Equipment, Net 28,967 38,040
Restricted Cash 45,000 45,000
Goodwill and In-Process R&D 5,438,210 5,438,210
Other Assets 354,772 55,314
Total Assets 18,313,431 9,730,602
Current Liabilities:    
Accounts Payable 970,912 1,412,128
Accrued Expenses 1,166,452 1,670,930
Deferred Revenue 8,861,400 4,225,000
Total Current Liabilities 10,998,764 7,308,058
Non-Current Liabilities:    
Contingent Consideration 1,210,000 1,210,000
Deferred Tax Liability 1,525,896 1,525,896
Long-Term Portion of Capital Lease Obligation 9,746 16,069
Total Non-Current Liabilities 2,745,642 2,751,965
Total Liabilities 13,744,406 10,060,023
Commitments and Contingencies (Note 8)
Stockholders’ Equity (Deficit):    
Preferred Stock, $0.01 par value: 9,995,828 and 9,997,223 shares authorized at June 30, 2017 and December 31, 2016, respectively; 3,750 designated Series A, 0 shares issued and outstanding at June 30, 2017 and December 31, 2016; 10,000 designated Series B, 600 and 0 issued and outstanding at June 30, 2017 and December 31, 2016, respectively 6 0
Common Stock, $0.01 par value: 100,000,000 shares authorized; 17,204,778 and 10,130,883 shares issued and outstanding at June 30, 2017 and December 31, 2016, respectively 172,048 101,309
Additional Paid-In Capital 89,177,942 78,106,645
Accumulated Deficit (84,845,255) (78,598,738)
Stockholder Note Receivable (58,824) (58,824)
Accumulated Other Comprehensive Income 123,108 120,187
Total Stockholders’ Equity (Deficit) 4,569,025 (329,421)
Total Liabilities and Stockholders’ Equity (Deficit) $ 18,313,431 $ 9,730,602